Network News
-
EBUS nodal staging in early-stage non-small cell lung cancer
EBUS-TBNA disrupted the field of bronchoscopy by offering a minimally invasive, real-time imaging approach to biopsy, but recent data have emerged that show routine use of EBUS may warrant scrutiny.
-
Considerations for single parents with terminal illness
Clinicians often focus more on what happens in the hospital than on issues beyond the hospital. This article covers the complex end-of-life issues that clinicians should consider for seriously ill patients with minor children.
-
Oral medications for sleep in nonintubated ICU patients and their impact on delirium
Clinicians rank pharmacologic sleep aids for ICU patients who are not intubated, beginning with those that have the strongest evidence for safety and efficacy.
-
Medical preparedness and critical care for the 2026 FIFA World Cup
In 2026, the FIFA World Cup will land in North America, whose health care infrastructure must be equipped to handle infectious disease threats, health care surges, mass casualty events, routine injuries, and chronic conditions.
-
Sex as a factor in endotracheal tube and tidal volume selection
Accounting for a patient’s sex and, by extension, height when considering invasive mechanical ventilation can inform personalized medicine in two key ways: endotracheal tube selection and tidal volume selection.
-
The emerging role of biologic therapy in asthma-COPD overlap
Biologics such as dupilumab, mepolizumab, benralizumab, and tezepelumab are an emerging option for select patients with asthma-COPD overlap, particularly those with T2-high inflammatory phenotypes.
-
Update on the evaluation and management of interstitial lung abnormalities
New guidelines from ATS outline the screening and follow-up procedures for interstitial lung abnormalities as well as define who is at higher risk for progressing to ILD.
-
Aspergillus in bronchiectasis: An expanding spectrum of disease and diagnostic challenge
Recent findings underscore the need to integrate Aspergillus serologies into routine bronchiectasis care and adopt a phenotype-driven, personalized approach to fungal surveillance and treatment.
-
In our navigational bronchoscopy ERA
The VERITAS trial is a turning point for interventional pulmonology, ushering in an era of high-quality comparative effectiveness trials poised to transform our approach to technology evaluation, implementation, and, ultimately, patient care.
-
Airway pressure release ventilation: Should it be used in the early stages of ARDS?
APRV has traditionally been viewed as a salvage therapy for patients with ARDS, but recent literature suggests that it can provide better overall lung recruitment with less sedation and more ventilator-free days.
